Cost-Utility Analysis Evaluating Vortioxetine Versus Venlafaxine XR and Agomelatine in the Treatment of Major Depressive Disorder in Taiwan
Nov 1, 2016, 00:00
10.1016/j.jval.2016.08.531
https://www.valueinhealthjournal.com/article/S1098-3015(16)31111-1/fulltext
Title :
Cost-Utility Analysis Evaluating Vortioxetine Versus Venlafaxine XR and Agomelatine in the Treatment of Major Depressive Disorder in Taiwan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31111-1&doi=10.1016/j.jval.2016.08.531
First page :
A841
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2474